FDA approves Papzimeos as first therapy for HPV-caused airway disease
The US Food and Drug Administration (FDA) has approved the first treatment for recurrent respiratory papillomatosis (RRP), a rare respiratory…
Infectious Disease
-
-
Basilea secures rights to Venatorx’s antibiotic for complicated UTIs
Basilea has acquired the global rights for Venatorx Pharmaceuticals’ ceftibuten-ledaborbactam etzadroxil, an antibiotic being developed for the treatment of complicated…
-
GSK’s oral antibiotic for gonorrhoea set for FDA review
A new pill that combats antibiotic-resistant strains of gonorrhoea has inched closer to approval in the US, after the US…
-
FDA removes Ixchiq partial pause but tightens vaccine’s use
The US Food and Drug Administration (FDA) has lifted a pause in the use of Valneva’s chikungunya vaccine Ixchiq in…
-
GSK’s world-first gonorrhoea vaccine launched in England
England has launched a world-first gonorrhoea vaccination programme that will potentially help avert up to 100,000 cases of the disease…
-
Flu vaccine strategy on the line as new US leaders anticipated to take charge
As countries in the Northern hemisphere deal with the flu season, experts say regulation surrounding flu vaccines could be due…
-
Better prevention and treatment options needed for genital herpes, WHO says
A World Health Organization (WHO) director has called for “better prevention and treatment options” after the agency released new estimates…
-
PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amass
Research activity in the human immunodeficiency viruses space (HIV) is pivoting towards pre-exposure prophylaxis (PrEP) therapies as vaccine failures rack…
-
Oxford Nanopore and UK to develop pathogen surveillance system
Oxford Nanopore has entered a strategic partnership with the UK Government to create a pathogen surveillance system in the National…
-
Matinas BioPharma mulls wind-down as antifungal therapy deal falls through
Matinas BioPharma has halted all product development activities and fired 80% of its staff, including three members of senior management,…
